FLURAZEPAM Drug Patent Profile
✉ Email this page to a colleague
When do Flurazepam patents expire, and what generic alternatives are available?
Flurazepam is a drug marketed by Chartwell Rx, Halsey, Hikma Intl Pharms, Novitium Pharma, Purepac Pharm, Rising, Sun Pharm Industries, Superpharm, Usl Pharma, and Warner Chilcott. and is included in twenty-one NDAs.
The generic ingredient in FLURAZEPAM is flurazepam hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the flurazepam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flurazepam
A generic version of FLURAZEPAM was approved as flurazepam hydrochloride by RISING on November 27th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLURAZEPAM?
- What are the global sales for FLURAZEPAM?
- What is Average Wholesale Price for FLURAZEPAM?
Summary for FLURAZEPAM
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for FLURAZEPAM |
| DailyMed Link: | FLURAZEPAM at DailyMed |


